Efficacy and Safety of Single-Agent Quizartinib (Q), Potent and SeleEfficacy and Safety of Single-Agent Quizartinib (Q), a Potent and Selective FLT3 Inhibitor (FLT3i), in Patients (pts) with FLT3-Internal Tandem Duplication (FLT3-ITD)-Mutated Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) Enrolled in the Global, Phase 3, Randomized Controlled QuANTUM-R Trial

被引:0
作者
Cortes, J. E. [1 ]
Khaled, S. K. [2 ]
Martinelli, G. [3 ]
Perl, A. E. [4 ]
Ganguly, S. [5 ]
Russell, N. H. [6 ]
Kramer, A. [7 ,8 ]
Dombret, H. [9 ]
Hogge, D. [10 ]
Jonas, B. A. [11 ]
Leung, A. Y. -H. [12 ]
Mehta, P.
Montesinos, P. [13 ,14 ]
Radsak, M. P. [15 ]
Sica, S. [16 ]
Arunachalam, M.
Holmes, M. [17 ]
Kobayashi, K. [17 ]
Namuyinga, R. [17 ]
Ge, N. [17 ]
Yver, A. [18 ]
Zhang, Y. [17 ]
Levis, M. J. [19 ]
机构
[1] Univ Texas Houston, Dept Leukemia, Houston, TX USA
[2] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[3] Ist Sci Romagnolo Studio Cura Tumori, Meldola, Italy
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] Univ Kansas, Westwood, England
[6] Nottingham Univ Hosp, Nottingham, England
[7] Univ Heildeelberg, Heidelberg, Germany
[8] German Canc Res Ctr, Heidelberg, Germany
[9] Univ Paris Diderot, St Louis Hosp, Paris, France
[10] Vancouver Gen Hosp, Vancouver, BC, Canada
[11] Univ Calif Davis, Comprehens Canc Ctr, Sacramento, CA 95817 USA
[12] Univ Hong Kong, Hong Kong, Peoples R China
[13] Univ Bristol, Bristol, Avon, England
[14] Hosp Univ & Politecn la Fe, Valencia, Spain
[15] Johannes Gutenburg Univ, Univ Med Ctr, Mainz, Germany
[16] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy
[17] Daiichi Sankyo Inc, Basking Ridge, NJ USA
[18] Daiichi Sankyo, Basking Ridge, NJ USA
[19] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BSH19-PO-0
引用
收藏
页码:78 / 78
页数:1
相关论文
empty
未找到相关数据